Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

International Bio Recovery Corporation V.IBR



TSXV:IBR - Post by User

Post by Flexy6on Oct 16, 2006 2:36pm
172 Views
Post# 11509953

Release

ReleaseIBR announces filing of provisional U.S. patent application Monday October 16, 12:57 pm ET VANCOUVER, Oct. 16 /CNW/ - International Bio Recovery Corporation (IBR), (www.ibrcorp.com) an environmental biotech company with a proprietary technology, enhanced autogenous thermophilic aerobic digestion (EATAD) to convert organic waste into environmentally progressive soil fertility products, announced today that it has filed a provisional application for a U.S. patent covering bacteria that produce products that may be used in a range of applications including promoting plant growth, suppression of plant pathogens and other uses. In making this announcement Steve Leptick, President and CEO of IBR states, "It is important for IBR to protect the intellectual property that is being developed through our research and development efforts. Following many years of positive growing trials using IBR fertility products, the active ingredients that are producing the favourable results have considerable potential for further commercialization and IP protection is essential." For further information Steve Leptick, President and Chief Executive Officer, IBR, (604) 924-1023 ext 304, (604) 924-1043 fax, info@ibrcorp.com Henry J. Bow, Vice President, IBR, (604) 924-1023 ext 309, (604) 924-1043 fax, hbow@ibrcorp.com
<< Previous
Bullboard Posts
Next >>